Can a combined contraceptive pill be used to treat low estrogen levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Combined Contraceptive Pills for Low Estrogen Treatment

Combined contraceptive pills are not recommended for treating low estrogen levels, as they are designed for contraception rather than hormone replacement therapy and may carry unnecessary risks. 1

Understanding Hormone Replacement vs. Contraception

Combined contraceptive pills (COCs) contain synthetic estrogen (usually ethinyl estradiol) and progestin designed primarily to prevent pregnancy. They work by:

  • Suppressing natural ovarian function
  • Providing synthetic hormones at doses calibrated for contraception
  • Creating a consistent hormonal environment to prevent pregnancy

Why COCs Are Not Appropriate for Low Estrogen Treatment:

  1. Inappropriate Hormone Type:

    • COCs contain ethinyl estradiol, not bioidentical 17β-estradiol needed for hormone replacement 1
    • Ethinyl estradiol is 10-20 times more potent than natural estrogen but less effective at addressing symptoms of estrogen deficiency
  2. Increased Health Risks:

    • COCs carry increased risk of venous thromboembolism (3-9 per 10,000 woman-years) 2
    • Contraindicated in women with certain medical conditions including history of stroke, heart disease, thrombogenic mutations, and complicated valvular heart disease 2

Appropriate Treatment for Low Estrogen

For women with low estrogen levels (such as in premature ovarian insufficiency or menopause), the recommended treatment is:

First-line Treatment:

  • Transdermal 17β-estradiol (patches releasing 50-100 μg/24 hours) 1
    • Avoids first-pass hepatic metabolism
    • Better bone mass accrual
    • Lower cardiovascular risk

Second-line Treatment:

  • Oral 17β-estradiol (1-2 mg daily) 1
    • Used when transdermal administration is contraindicated or refused

Progestin Component:

  • For women with an intact uterus, progestin must be added for endometrial protection
  • Micronized progesterone is preferred (200 mg daily for 12-14 days per month) 1

Special Considerations

For Women Also Needing Contraception:

If contraception is also required, consider:

  • 17β-estradiol-based combined oral contraceptives (17β-estradiol + nomegestrol acetate or 17β-estradiol + dienogest) 1
  • These provide more physiologic estrogen than traditional COCs but are still primarily contraceptives

For Women with Contraindications to Estrogen:

  • Progestin-only pills (POPs) 3
  • Levonorgestrel IUD 2
  • Copper IUD 2

Common Pitfalls to Avoid

  1. Confusing contraception with hormone replacement therapy:

    • Different formulations with different purposes
    • Different risk-benefit profiles
  2. Ignoring contraindications to estrogen therapy:

    • Smoking in women ≥35 years
    • History of thromboembolism
    • Uncontrolled hypertension
    • Migraine with aura 2, 4
  3. Overlooking the need for endometrial protection:

    • Women with an intact uterus need progestin to prevent endometrial hyperplasia

Conclusion

For treating low estrogen levels, hormone replacement therapy with bioidentical 17β-estradiol (preferably transdermal) is the appropriate treatment, not combined contraceptive pills. Treatment should be tailored to address symptoms of estrogen deficiency while minimizing risks.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Venous Thromboembolism Risk and Contraception

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.